[H-3] PAROXETINE BINDING AND SEROTONIN CONTENT OF RAT-BRAIN - ABSENCE OF CHANGES FOLLOWING ANTIDEPRESSANT TREATMENTS

被引:32
作者
DEWAR, KM
GRONDIN, L
NENONENE, EK
OHAYON, M
READER, TA
机构
[1] UNIV MONTREAL, FAC MED, CTR RECH FERNAND SEGUIN, DEPT PSYCHIAT, MONTREAL H3C 3J7, QUEBEC, CANADA
[2] UNIV MONTREAL, FAC MED, CTR RECH SCI NEUROL, DEPT PHYSIOL, MONTREAL H3C 3J7, QUEBEC, CANADA
基金
英国医学研究理事会;
关键词
IMIPRAMINE; TRIMIPRAMINE; FLUOXETINE; 5-HIAA (5-HYDROXYINDOLE-3-ACETIC ACID); 5-HT UPTAKE;
D O I
10.1016/0014-2999(93)90833-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The high affinity binding of [H-3]paroxetine was measured in rat cerebral cortex following chronic treatment (21 days) with imipramine (5 mg/kg), trimipramine (5 mg/kg) and fluoxetine (2 mg/kg),in adult (3-4 months) or neonatal (7 days of age) rats. Tissue concentrations of serotonin and of its metabolite 5-hydroxyindole-3-acetic acid were also determined by high-performance liquid chromatography in cingulate cerebral cortex, rostral neostriatum, hippocampus and midbrain raphe nucleus region. No differences were found in any of the parameters of [H-3]paroxetine binding after antidepressant administration, in either adult or neonatal animals. In addition, endogenous serotonin and 5-hydroxyindole-3-acetic acid levels were not different from control values in any of the regions examined. The present study shows that the serotonin uptake recognition site is resilient to changes after chronic treatment with therapeutic doses of antidepressants, and emphasizes the potential usefulness of uptake site ligands as markers to quantify innervation densities within the brain.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 17 条
[1]  
ALPERS HS, 1972, J PHARMACOL EXP THER, V180, P531
[2]   CENTRAL AND PERIPHERAL 5-HT UPTAKE IN RATS TREATED CHRONICALLY WITH FEMOXETINE, PAROXETINE, AND CHLORIMIPRAMINE [J].
BUUSLASSEN, J ;
LUND, J ;
SONDERGAARD, I .
PSYCHOPHARMACOLOGY, 1980, 68 (03) :229-233
[3]   EFFECTS OF SHORT-TERM AND LONG-TERM ADMINISTRATION OF FLUOXETINE ON THE MONOAMINE CONTENT OF RAT-BRAIN [J].
CACCIA, S ;
FRACASSO, C ;
GARATTINI, S ;
GUISO, G ;
SARATI, S .
NEUROPHARMACOLOGY, 1992, 31 (04) :343-347
[4]  
CHARNEY DS, 1981, ARCH GEN PSYCHIAT, V38, P1160
[5]   [H-3] PAROXETINE BINDING AND SEROTONIN CONTENT OF RAT CORTICAL AREAS, HIPPOCAMPUS, NEOSTRIATUM, VENTRAL MESENCEPHALIC TEGMENTUM, AND MIDBRAIN RAPHE NUCLEI REGION FOLLOWING PARA-CHLOROPHENYLALANINE AND PARA-CHLOROAMPHETAMINE TREATMENT [J].
DEWAR, KM ;
GRONDIN, L ;
CARLI, M ;
LIMA, L ;
READER, TA .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (01) :250-257
[6]   [H-3] PAROXETINE BINDING AND SEROTONIN CONTENT OF RAT AND RABBIT CORTICAL AREAS, HIPPOCAMPUS, NEOSTRIATUM, VENTRAL MESENCEPHALIC TEGMENTUM, AND MIDBRAIN RAPHE NUCLEI REGION [J].
DEWAR, KM ;
READER, TA ;
GRONDIN, L ;
DESCARRIES, L .
SYNAPSE, 1991, 9 (01) :14-26
[7]   EFFECT OF CHRONIC TREATMENT WITH SELECTIVE MONOAMINE-OXIDASE INHIBITORS AND SPECIFIC 5-HYDROXYTRYPTAMINE UPTAKE INHIBITORS ON [H-3] PAROXETINE BINDING TO CEREBRAL CORTICAL MEMBRANES OF THE RAT [J].
GRAHAM, D ;
TAHRAOUI, L ;
LANGER, SZ .
NEUROPHARMACOLOGY, 1987, 26 (08) :1087-1092
[8]   A COMMON BINDING-SITE FOR TRICYCLIC AND NONTRICYCLIC 5-HYDROXYTRYPTAMINE UPTAKE INHIBITORS AT THE SUBSTRATE RECOGNITION SITE OF THE NEURONAL SODIUM-DEPENDENT 5-HYDROXYTRYPTAMINE TRANSPORTER [J].
GRAHAM, D ;
ESNAUD, H ;
HABERT, E ;
LANGER, SZ .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (21) :3819-3826
[9]   CHARACTERIZATION OF [H-3] PAROXETINE BINDING TO RAT CORTICAL MEMBRANES [J].
HABERT, E ;
GRAHAM, D ;
TAHRAOUI, L ;
CLAUSTRE, Y ;
LANGER, SZ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (1-2) :107-114
[10]  
HRDINA PD, 1990, J PHARMACOL EXP THER, V252, P410